ATE360682T1 - Neue galactooligosaccharidzusammensetzung und herstellung davon - Google Patents

Neue galactooligosaccharidzusammensetzung und herstellung davon

Info

Publication number
ATE360682T1
ATE360682T1 AT04743163T AT04743163T ATE360682T1 AT E360682 T1 ATE360682 T1 AT E360682T1 AT 04743163 T AT04743163 T AT 04743163T AT 04743163 T AT04743163 T AT 04743163T AT E360682 T1 ATE360682 T1 AT E360682T1
Authority
AT
Austria
Prior art keywords
novel
new
production
growth
mixture
Prior art date
Application number
AT04743163T
Other languages
German (de)
English (en)
Inventor
Anthony Graham Wynne
Glenn Gibson
Jacek Witold Slupinski
Georgios Tzortis
Original Assignee
Clasado Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33568264&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE360682(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0315266A external-priority patent/GB0315266D0/en
Priority claimed from GB0325224A external-priority patent/GB0325224D0/en
Priority claimed from GB0405837A external-priority patent/GB0405837D0/en
Application filed by Clasado Inc filed Critical Clasado Inc
Application granted granted Critical
Publication of ATE360682T1 publication Critical patent/ATE360682T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
AT04743163T 2003-06-30 2004-06-30 Neue galactooligosaccharidzusammensetzung und herstellung davon ATE360682T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0315266A GB0315266D0 (en) 2003-06-30 2003-06-30 Novel galactooligosaccharide composition and the preparation thereof
GB0325224A GB0325224D0 (en) 2003-10-29 2003-10-29 Novel galactooligosaccharide composition and the preparation thereof
GB0405837A GB0405837D0 (en) 2004-03-16 2004-03-16 Novel Galactooligosaccharide composition and the preparation thereof

Publications (1)

Publication Number Publication Date
ATE360682T1 true ATE360682T1 (de) 2007-05-15

Family

ID=33568264

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04743163T ATE360682T1 (de) 2003-06-30 2004-06-30 Neue galactooligosaccharidzusammensetzung und herstellung davon

Country Status (21)

Country Link
US (1) US7883874B2 (en:Method)
EP (1) EP1644482B2 (en:Method)
JP (2) JP4384656B2 (en:Method)
KR (1) KR100857500B1 (en:Method)
AT (1) ATE360682T1 (en:Method)
AU (1) AU2004254110B2 (en:Method)
BR (1) BRPI0408911B1 (en:Method)
CA (1) CA2520043C (en:Method)
CY (1) CY1107671T1 (en:Method)
DE (1) DE602004006133T3 (en:Method)
DK (1) DK1644482T4 (en:Method)
ES (1) ES2284028T5 (en:Method)
GB (1) GB2412380B (en:Method)
IL (1) IL172553A (en:Method)
MX (1) MXPA05010349A (en:Method)
NO (1) NO335413B1 (en:Method)
NZ (1) NZ542482A (en:Method)
PL (1) PL1644482T5 (en:Method)
PT (1) PT1644482E (en:Method)
RU (1) RU2313572C2 (en:Method)
WO (1) WO2005003329A1 (en:Method)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0408911B1 (pt) * 2003-06-30 2016-07-26 Clasado Inc composição de galactooligossacarídeos e a preparação da mesma
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
GB0522740D0 (en) * 2005-11-08 2005-12-14 Clasado Inc Process for the production of oligosaccharides
GB0525857D0 (en) 2005-12-20 2006-02-01 Product and process
EP1803358A1 (en) 2005-12-28 2007-07-04 Laboratorios Ordesa, S.L Infant immunological formula
GB0601901D0 (en) 2006-01-31 2006-03-08 Product and Process
EP1988786B2 (en) † 2006-02-10 2019-10-09 Société des Produits Nestlé S.A. Oligosaccharide mixture
GB0606112D0 (en) * 2006-03-28 2006-05-03 Product and process
FR2900029B1 (fr) * 2006-04-25 2012-09-14 Bel Fromageries Procede d'aromatisation de produits fromagers.
EP1887017A1 (en) * 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate
PT2076271E (pt) 2006-10-02 2011-12-02 Friesland Brands Bv Inibição de toxinas da cólera por galacto-oligossacáridos (gos)
EP1988096A1 (en) * 2007-04-26 2008-11-05 Laboratorios Ordesa, S.L Process for preparing a galactooligosaccharides powder
JP5455244B2 (ja) * 2008-03-12 2014-03-26 タタ ケミカルズ リミテッド 遊離細胞によるガラクトオリゴ糖の製造方法
GB0809921D0 (en) * 2008-05-30 2008-07-09 Clasado Inc Product and process therefor
US20090297660A1 (en) * 2008-06-02 2009-12-03 Kraft Food Holdings, Inc. Cheese Products Containing Galacto-Oligosaccharides And Having Reduced Lactose Levels
SG10201901259RA (en) 2009-02-24 2019-03-28 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
KR101121161B1 (ko) * 2009-02-24 2012-03-19 주식회사 제노포커스 고당전이 활성의 신규한 베타-갈락토시다제 및 그 용도
WO2010105207A1 (en) * 2009-03-13 2010-09-16 The Regents Of The University Of California Prebiotic oligosaccharides
GB0906983D0 (en) 2009-04-23 2009-06-03 Clasado Inc Novel use
UA104469C2 (uk) 2009-05-27 2014-02-10 Класадо Інк. Спосіб запобігання діареї мандрівників
TWI446914B (zh) * 2009-06-04 2014-08-01 Clasado Inc 製備預防旅人腹瀉發生藥物之組成物之用途
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
IT1395068B1 (it) 2009-08-07 2012-09-05 Inalco Spa Processo per la produzione di galatto-oligosaccaridi ultrapuri
US20110189342A1 (en) * 2010-02-01 2011-08-04 Jeong Hea-Seok High-purity galactooligosaccharides and uses thereof
IL206678A0 (en) 2010-06-28 2010-12-30 Hcl Cleantech Ltd A method for the production of fermentable sugars
AR082261A1 (es) * 2010-07-19 2012-11-21 Arla Foods Amba Composicion que contiene galacto-oligosacaridos y un metodo para producirla
JP2017018135A (ja) * 2010-07-19 2017-01-26 アルラ フーズ アムバＡｒｌａ Ｆｏｏｄｓ Ａｍｂａ ガラクトオリゴ糖含有組成物およびそれを生産する方法
PT2481299T (pt) * 2011-01-31 2017-03-08 Synformulas Gmbh Estirpes de bifidobacterium bifidum para aplicação em doenças gastrointestinais
GB2492559B (en) * 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
WO2013016111A1 (en) 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
JP5980785B2 (ja) * 2011-09-08 2016-08-31 株式会社ヤクルト本社 新規ビフィズス菌及びその利用
US9617608B2 (en) 2011-10-10 2017-04-11 Virdia, Inc. Sugar compositions
EP2775852B1 (en) * 2011-10-18 2016-08-17 Nestec S.A. Composition for use in brain growth and/or cognitive and/or psychomotor development
GB2511993B (en) * 2011-11-30 2019-09-18 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
US20130172546A1 (en) 2011-12-30 2013-07-04 Renmatix, Inc. Compositions comprising c5 and c6 oligosaccharides
CA2863681A1 (en) 2012-02-14 2013-08-22 The Procter & Gamble Company Topical use of a skin-commensal prebiotic agent and compositions containing the same
GB201305708D0 (en) 2013-03-28 2013-05-15 Clasado Inc Novel use
US11116235B2 (en) 2013-05-24 2021-09-14 General Mills, Inc. Food products with yogurt whey
ES2649217T3 (es) * 2013-07-26 2018-01-10 Novozymes A/S Polipéptidos que tienen actividad de alfa-L-galactosidasa y polinucleótidos que los codifican
US20160219916A1 (en) * 2013-08-30 2016-08-04 Abbott Laboratories Oral rehydration compositions with galactooligosaccharides
GB201319531D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition & methods of screening
US10695358B2 (en) 2013-12-20 2020-06-30 Abbott Laboratories Oral rehydration composition with oligosaccharides
EP2896628B1 (en) * 2014-01-20 2018-09-19 Jennewein Biotechnologie GmbH Process for efficient purification of neutral human milk oligosaccharides (HMOs) from microbial fermentation
CA2954662C (en) 2014-07-09 2024-03-19 Midori Usa, Inc. Oligosaccharide compositions and methods for producing thereof
US11116805B2 (en) 2014-11-19 2021-09-14 Kabushiki Kaisha Yakult Honsha Preventive and therapeutic agent for celiac disease
US11078548B2 (en) 2015-01-07 2021-08-03 Virdia, Llc Method for producing xylitol by fermentation
EP4209130A1 (en) 2015-01-26 2023-07-12 DSM Nutritional Products, LLC Oligosaccharide compositions for use animal feed and methods of producing thereof
MX381376B (es) 2015-01-26 2025-03-12 Kaleido Biosciences Inc Preparaciones terapéuticas de glicanos y métodos relacionados con estas.
SI3285777T1 (sl) 2015-04-23 2022-02-28 Kaleido Biosciences, Inc. Glikanski terapevtiki in postopki zdravljenja
CN107849620B (zh) 2015-05-27 2022-01-11 威尔迪亚有限责任公司 用于处理木质纤维素材料的综合方法
US10190142B2 (en) 2016-01-25 2019-01-29 King-Prebiotics Biotechnology (Tw) Co., Ltd. High-purity galactooligosaccharide compositions, preparations, and applications thereof
ES2978987T3 (es) * 2016-06-24 2024-09-23 Yessinergy Holding S/A Composición inmunomoduladora y promotora del crecimiento que controla la población de bacterias indeseables en la microbiota intestinal
US20190290675A1 (en) 2016-12-06 2019-09-26 Kaleido Biosciences, Inc. Glycan polymers and related methods thereof
KR101955251B1 (ko) 2017-07-31 2019-03-08 최승오 독서대 겸용 얼굴베개
JP7576375B2 (ja) 2017-11-03 2024-10-31 カレイド・バイオサイエンシズ・インコーポレイテッド グリカン調製物及び高アンモニア血症のための使用方法
US20200352980A1 (en) 2017-11-03 2020-11-12 Kaleido Biosciences, Inc. Glycan preparations for the treatment of infection
JP2021534193A (ja) 2018-08-21 2021-12-09 カレイド・バイオサイエンシズ・インコーポレイテッド オリゴ糖組成物およびアンモニアレベルを低下させるためのその使用方法
AU2019377869A1 (en) 2018-11-08 2021-05-27 Kaleido Biosciences, Inc. Oligosaccharide compositions and methods of use thereof
CN113613511A (zh) * 2019-03-29 2021-11-05 株式会社益力多本社 来自饮食的多醣的利用性高的新型双歧杆菌属细菌
WO2020229690A1 (en) * 2019-05-15 2020-11-19 N.V. Nutricia Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases
CN117693295A (zh) * 2021-07-01 2024-03-12 N·V·努特里奇亚 用于肠道屏障功能的营养组合物
GB202200069D0 (en) * 2022-01-05 2022-02-16 Vemico Ltd Compositions and methods for immunomodulation via control of intestinal microbiome
GB2619977A (en) * 2022-06-24 2023-12-27 Clasado Res Services Limited Compositions and uses thereof
GB2623336A (en) * 2022-10-12 2024-04-17 Clasado Res Services Limited Compositions and uses thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435389A (en) 1980-07-07 1984-03-06 Kabushiki Kaisha Yakult Honsha Composition for promoting growth of bifidobacteria
JPS6259290A (ja) 1985-09-09 1987-03-14 Riyoushiyoku Kenkyukai イソラフイノ−ス及びその製造方法
JP2711095B2 (ja) 1986-09-27 1998-02-10 ユニチカ株式会社 ビフイドバクテリウム菌の増殖促進剤の製造法
DK199887D0 (da) 1987-04-15 1987-04-15 Danisco Bioteknologi As Gaerstamme
JP2518663B2 (ja) 1987-12-24 1996-07-24 株式会社ヤクルト本社 ガラクトオリゴ糖含有加工乳の製造法
US5149640A (en) 1988-12-22 1992-09-22 Ajinomoto Co., Inc. Method for producing galactose transfer products
JP2819313B2 (ja) 1989-07-18 1998-10-30 焼津水産化学工業株式会社 Ｎ―アセチルラクトサミンの製造方法
JP2819312B2 (ja) 1989-07-18 1998-10-30 焼津水産化学工業株式会社 Ｎ―アセチルラクトサミンの製造法
CA2027835A1 (en) 1990-01-19 1991-07-20 William D. Prevatt Strains of phaffia rhodozyma containing high levels of astaxanthin
JP2750767B2 (ja) 1990-02-21 1998-05-13 雪印乳業株式会社 新規糖アルコール
JP2952439B2 (ja) † 1991-11-26 1999-09-27 株式会社ホーネンコーポレーション 新規飲食品素材
JPH05146296A (ja) 1991-11-27 1993-06-15 Yakult Honsha Co Ltd β−ガラクトシダーゼ遺伝子を含むＤＮＡ断片及び該ＤＮＡ断片を組み込んだプラスミド
JP2904687B2 (ja) 1993-09-17 1999-06-14 雪印乳業株式会社 新規オリゴ糖
FR2723963B1 (fr) 1994-08-31 1997-01-17 Gervais Danone Co Preparation de produits fermentes par streptococcus thermophilus, enrichis en galacto-oligosaccharides et en beta-galactosidase
JP3246296B2 (ja) 1995-11-09 2002-01-15 宇部興産株式会社 半溶融金属の成形方法
JPH1023898A (ja) 1996-07-10 1998-01-27 Meiji Milk Prod Co Ltd Ｎ−アセチルラクトサミン誘導体の新規な製造法
KR100245383B1 (ko) 1996-09-13 2000-03-02 정훈보 교차홈 형성 전열관 및 그 제조 방법
JP2894293B2 (ja) 1996-09-17 1999-05-24 不二製油株式会社 ガラクタナーゼｓ−３９及びこれを産生するバチルスエスピーｓ−３９
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
JP3049693B1 (ja) 1998-12-10 2000-06-05 ソフィアインターナショナル株式会社 端末ターミナル
FR2789086B1 (fr) 1999-02-03 2003-01-31 Alain Rambach Procede de detection de bacteries cultivees en condition anaerobie
EP1283876B1 (en) * 2000-05-26 2007-01-24 Arla Foods amba Beta-galactosidase isolated from bifidobacterium
EP1227152A1 (en) 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Bacterial strain and genome of bifidobacterium
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
GB0303716D0 (en) 2003-02-18 2003-03-19 Mars Uk Ltd Food product and process
BRPI0408911B1 (pt) * 2003-06-30 2016-07-26 Clasado Inc composição de galactooligossacarídeos e a preparação da mesma

Also Published As

Publication number Publication date
JP4384656B2 (ja) 2009-12-16
WO2005003329A1 (en) 2005-01-13
RU2005129997A (ru) 2006-06-10
EP1644482A1 (en) 2006-04-12
US20070274955A1 (en) 2007-11-29
CA2520043C (en) 2009-09-01
PL1644482T3 (pl) 2007-09-28
GB0513376D0 (en) 2005-08-03
JP2009189374A (ja) 2009-08-27
DE602004006133D1 (de) 2007-06-06
HK1077323A1 (en) 2006-02-10
GB2412380A (en) 2005-09-28
DK1644482T4 (da) 2014-12-15
PL1644482T5 (pl) 2015-05-29
JP2007527199A (ja) 2007-09-27
KR20050111624A (ko) 2005-11-25
DK1644482T3 (da) 2007-08-13
BRPI0408911A (pt) 2006-03-28
MXPA05010349A (es) 2006-03-08
RU2313572C2 (ru) 2007-12-27
US7883874B2 (en) 2011-02-08
EP1644482B1 (en) 2007-04-25
AU2004254110B2 (en) 2007-01-04
DE602004006133T3 (de) 2014-12-24
EP1644482B2 (en) 2014-10-01
JP4932874B2 (ja) 2012-05-16
BRPI0408911B1 (pt) 2016-07-26
AU2004254110A1 (en) 2005-01-13
GB2412380B (en) 2005-11-09
ES2284028T5 (es) 2014-12-04
DE602004006133T2 (de) 2007-11-22
ES2284028T3 (es) 2007-11-01
CY1107671T1 (el) 2013-04-18
KR100857500B1 (ko) 2008-09-08
PT1644482E (pt) 2007-06-25
NZ542482A (en) 2008-05-30
IL172553A0 (en) 2006-04-10
NO335413B1 (no) 2014-12-08
EP1644482B8 (en) 2007-10-03
IL172553A (en) 2010-06-30
NO20056004L (no) 2006-01-03
CA2520043A1 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
ATE360682T1 (de) Neue galactooligosaccharidzusammensetzung und herstellung davon
ATE463558T1 (de) Beta-galactosidase mit transgalactosylierungsaktivität
ZA200806175B (en) Galactosidalse with alpha-galactosyltransferase activity
MY144029A (en) Alpha-galactosidase from bifidobacterium bifidum and its use
EE05412B1 (et) Bifidobacterium'i perekonna probiootiliste tvede skriinimise meetod
GEU20061256Y (en) Yoghurt

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1644482

Country of ref document: EP